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Abstract  
Background: Private general practitioners in Malaysia largely operates as solo practices – prescribing and supplying medications to 
patients directly from their clinics, thus posing risk of medication-related problems to consumers. A pharmacy practice reform that 
integrates pharmacists into primary healthcare clinics can be a potential initiative to promote quality use of medication. This model of 
care is a novel approach in Malaysia and research in the local context is required, especially from the perspectives of pharmacists. 
Objective: To explore pharmacists’ views in integrating pharmacists into private GP clinics in Malaysia. 
Methods: A combination of purposive and snowballing sampling was used to recruit community and hospital pharmacists from urban 
areas in Malaysia to participate either in focus groups or semi-structured interviews. A total of 2 focus groups and 4 semi-structured 
interviews were conducted. Sessions were audio recorded, transcribed verbatim and thematically analysed using NVivo 10.  
Results: Four major themes were identified: (1) Limited potential to expand pharmacists’ roles, (2) Concerns about non-pharmacists 
dispensing medicines in private GP clinics, (3) Lack of trust from consumers and private GPs, (4) Cost implications. Participants felt that 
there was a limited role for pharmacists in private GP clinics. This was because the medication supply role is currently undertaken in 
private GP clinics without the need of pharmacists. The perceived lack of trust from consumers and private GPs towards pharmacists 
arises from the belief that healthcare is the GPs’ responsibility. This suggests that there is a need for increased public and GP 
awareness towards the capabilities of pharmacists’ in medication management. Participants were concerned about an increase in cost 
to private GP visits if pharmacists were to be integrated. Nevertheless, some participants perceived the integration as a means to 
reduce medical costs through improved quality use of medicines.  
Conclusion: Findings from the study provided a better understanding to help ascertain pharmacists’ views on their readiness and 
acceptance in a potential new model of practice. 
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INTRODUCTION 
Primary healthcare services in Malaysia are mainly 
provided by two sectors: the public health clinics which are 
fully funded by the government and the fee-for-service 
private sector, including private general practitioner (GP) 
clinics and community pharmacies.1  
In Malaysia, private GPs mainly operate as solo practices 
with little coordination with other healthcare providers.2 
Furthermore, physicians are allowed to operate a small 
dispensary within their clinics in Malaysia. Throughout the 
years, private GPs in Malaysia are granted rights under the 
Poison Act 1952 to prescribe and supply medications 
directly from their clinics. Private GPs hire non-pharmacists 
to dispense medications, further limiting the opportunities 
for pharmacists to extend their professional duties. 
Community pharmacists in Malaysia are often underutilised 
and operate under rigid condition.3 The general public 
usually consults the community pharmacists to purchase a 
particular prescription medicine or over-the-counter 
products.4 Patient counselling is offered free of charge as 
part of professional pharmacy services and dispensing fees 
are not incurred. 
Private sector services are funded by out-of-pocket 
payments and increasingly through third party funds such 
as private health insurance schemes and corporations that 
arrange for healthcare funding for their employees.5 
Although private sector services are paid out-of-pocket, 
consumers are increasingly utilising private healthcare 
facilities due to easier accessibility and shorter patient 
waiting times.6 However, information sharing between the 
healthcare settings is absent leading to fragmentation of 
care, thus increasing risk to polypharmacy and medications 
errors.7,8 Polypharmacy is common among the elderly and 
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those with multiple chronic diseases as they take more 
medications and are more at risk of medication related 
problems.9 These patients would ideally benefit from a 
clinical review of their medication regimens by 
pharmacists. Pharmacists as medication experts can 
improve patient outcomes by optimizing drug therapy and 
promoting quality use of medication.10,11 A pharmacy 
practice reform that integrates pharmacists into primary 
healthcare clinics can be a potential initiative to deliver 
comprehensive primary healthcare services to the public. 
These services are not limited to only dispensing 
medications and may include medication review, 
education, academic detailing, medication reconciliation, 
general practice preceptor, disease focused clinics, 
formulary development, and system level activities such as 
quality prescribing activities (prescribing audits).12-19  
One of the first few integrative practices studied in 
Malaysia was the Cardiovascular Risk Factors Intervention 
Strategies (CORFIS) trial.20 In the trial, hypertensive patients 
were recruited to either receive conventional care (only 
GP) or CORFIS care (allied healthcare team consisting of GP, 
pharmacist, dietician and nurse educator).20 In as early as 
six months, patients who received CORFIS care showed 
significantly better improvement in achieving target blood 
pressure (BP) and treatment adherence as compared to 
patients who were seen only by a GP.20 Despite the 
reported benefits, the study posted an important question 
on whether the significant improvement in BP outcomes 
was sustainable over a longer period of care. This warrants 
for follow-up investigations on facilitators and barriers of 
integrating pharmacists’ participation into GP clinics. 
Some reported challenges to the adoption and integration 
of expanded pharmacists’ roles within the healthcare 
system were GPs’ reservation and pharmacists themselves 
who often lacked confidence and are averse to risks.21,22 
Two studies in Malaysia reported reservations by the 
private GPs on key roles of pharmacists such as diagnosing 
minor ailments, maintain complete medication profile and 
drug information provider to physicians.23,24 A report of 
private GPs’ opinions on pharmacist integration revealed 
that they were concerned that collaborative practices with 
pharmacists may pose threat to the professional 
dominance and autonomy accorded to the private GPs in 
Malaysia.25 The attitudes, trust and understanding of GPs 
towards the skills and knowledge of pharmacists appear to 
be the greatest barrier towards integration of pharmacists 
into GP clinics.25 Similarly, healthcare consumers was also 
reported to have low expectations toward the role of 
pharmacists working within GP clinics, suggesting that 
engagement of pharmacists in health improvement 
activities tend to be passive and product-orientated.26 
Therefore, the importance of individual pharmacist 
assertiveness and conﬁdence is a key factor in overcoming 
many of the integration barriers.21,22 Pharmacists who 
possess these personality traits might be better suited to 
work in a multidisciplinary general practice setting. 
The lack of remuneration is a commonly expressed barrier 
preventing pharmacists from providing more clinical care 
services.27-29 However, a systematic review by Houle et al. 
showed that mere presence of remuneration scheme did 
not ensure uptake in practice.30 For example, pharmacist 
participation in the remuneration programs was found to 
vary considerably, with some programs reporting very low 
numbers of participating pharmacies31,32 and others 
reporting a high initial expression of interest but short 
persistence or very low patient enrolment over time.33-35 
Integrating pharmacists into GP clinics is a new notion in 
the Malaysian setting. This study aimed to provide insights 
on the views of pharmacists and to identify perceived 
facilitators and barriers of integrating pharmacists into 
private GP clinics. A better understanding of this area will 
help ascertain the readiness and acceptance of pharmacists 
in a potential new model of practice. 
 
METHODS 
This study received ethical clearance by the International 
Medical University Joint-Committee (IMU-JC) of Research 
and Ethics Committee (IMU R 117/2013). A Project 
Advisory Group (PAG) was formed consisting of 
representatives of key stakeholder organisations. The PAG 
was a committee of experts invited from Malaysia’s peak 
professional pharmacy and medical organisations, Ministry 
of Health, community pharmacy and pharmacy educators, 
who have agreed to share their knowledge with the 
researchers. The aim of the PAG was to discuss and assist 
the development of semi-structured interview questions 
and a questioning route for focus group discussions, guided 
by what is known in the literature as well as their expertise 
in the primary healthcare environment.  
Qualitative research using inductive approach from 
perspectives, feelings and experiences of pharmacists were 
engaged to generate novel insights on pharmacist 
integration into private GP clinics.36 For this purpose, data 
collection methods consisting of semi-structured interviews 
and focus groups were chosen since little is known about 
the topic in the Malaysian context. Semi-structured 
interviews were carried out with those who were unable to 
commit to a focus group session due to their busy 
schedule. The interviews and focus groups were conducted 
by one researcher (PSS) utilising an interview guide (Online 
Appendix) to ensure rigour and consistency in the 
questions asked. 
Sampling and recruitment 
Letters of invitation were disseminated to peak national 
professional pharmacy organisation and managers of ten 
community pharmacies to identify potential participants. 
Community pharmacists and private hospital pharmacists 
were engaged as participants as they would best represent 
the position of the pharmacist working within the private 
primary healthcare setting in this research. Recruitment 
was also done though snowballing technique as 
participants suggested potential candidates (if possible) 
within their social networks and expertise to participate in 
the study. The sample size was determined by data 
saturation and interviews were stopped when no new 
themes emerged from the interviews.  
Interview Guide and Validity 
A guide was used to conduct the interviews and focus 
groups. The guide was tested with a community pharmacist 
for face validation. Key topics in the guide included 
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Figure 1. General inductive approach 
potential roles of integrated pharmacist, barriers and 
facilitators to integration, the benefits to integration and 
pharmacists’ remuneration. Probing questions and 
examples of potential scenarios were provided where 
necessary to encourage participant engagement. To reduce 
interviewer bias, the probing questions common to all the 
focus groups and semi-structured interviews were used to 
facilitate discussion.  
Data collection 
Data was collected between September and October 2013. 
Written consent was obtained from all participants. 
Anonymous demographic data was collected from the 
participants through a short questionnaire prior to the start 
of each focus group and semi-structured interview. The 
interviews and focus groups were audio-recorded and 
transcribed verbatim. 
Interviews and focus groups were carried out at a mutually 
agreed place and facilitated by PSS. Field notes identifying 
the main points gleaned from the discussion were taken 
throughout the focus group and interview sessions. The 
semi-structured interviews, focus group discussion and 
field notes served to triangulate the data. All participants 
were offered a copy of their interview transcript for 
content verification. 
Data analysis 
Data was analysed using a general inductive approach to 
derive findings in the context of focused evaluation 
questions (Figure 1).37 Transcripts were read several times 
by two researchers (PSS, VM) to independently create a list 
of nodes and coding descriptions. An agreed framework of 
nodes was generated from a consensus among team 
members (PSS, VM, PSW). The researcher (PSS) coded all 
the transcripts based on the agreed framework of nodes 
using the NVivo 10 software (QSR, Melbourne). The nodes 
were regrouped into larger categories as a pattern of 
themes emerged from the data. Emerging themes were 
developed by studying the transcripts repeatedly and 
considering possible meanings and how these fitted with 
developing themes. Themes generated were then checked 
with the original transcripts to make sure they were 
grounded in the data.  
During the interpretation stage, researchers reviewed 
beyond descriptions of individual transcripts towards 
developing themes which offered possible explanations for 
what was happening within the data. This process was 
influenced both by the original research objectives and by 
new concepts generated inductively (participants’ 
experiences and views) from the data. Each theme was 
supported by verbatim quotations from participants that 
would best represent the idea of the theme. Towards the 
end of the study when no new theme emerged, this 
suggested that major themes had been identified. This is 
known as data saturation. Regular team meetings among 
the researchers (PSS, VM and PSW) facilitated critical 
exploration of participant responses, discussion of deviant 
cases and agreement on recurring themes. 
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RESULTS  
A total of 19 pharmacists participated in two focus groups 
and four semi-structured interviews. The focus groups ran 
for approximately one hour and semi-structured interviews 
each lasted 30 minutes on average. Mean age (SD) of the 
participants was 29.7 (SD=4.7) years, with a range of 25 to 
41 years. Demographic characteristics of participants are 
listed in Table 1. 
Four major themes emerged from the focus groups and 
semi-structured interviews and are supported by 
illustrative quotations from the participants (P = 
Pharmacist). A summary of themes and illustrative 
quotations is illustrated in Table 2.  
Theme 1: Pharmacists envisioned their main role as 
dispensing medications.  
All participants brought up the issue of non-pharmacy 
trained clinic staff dispensing medications to their patients. 
Some participants referred to the clinic staff as ‘nurses’, 
‘assistants’, ‘high school graduates’ and ‘technicians’. With 
the current state of practice, the participants were 
concerned about patient and medication safety in clinics 
since these clinic staff were largely not formally trained to 
supply medications. The participants strongly felt that the 
role of dispensing of medications should be best left to 
pharmacists. In addition, some participants added that the 
pharmacist can provide advice and medication information 
to the GPs when required. Most participants commented 
that the pharmacist working in the private GP clinic will be 
able to provide a check-and-balance mechanism before 
medications are dispensed to consumers. One of the 
participants stressed that prescribing and counter-checking 
of medications should not be carried out by the same 
person, i.e. GPs.  
Theme 2: Difficulty envisioning roles beyond medication 
supply  
(i) Limited roles for pharmacist in private GP clinics 
Most participants expressed that the potential pharmacist 
activities in private GP clinics include dispensing medication 
to consumers and providing medication information to 
private GPs. When enquired on other potential pharmacy 
services besides dispensing medications, most participants 
were unable to answer. They have not seen or experienced 
pharmacists working in private GP clinics before, therefore 
have not thought about it. Some participants also 
suggested to trial pharmacist working in private GP clinics 
to help visualise some of the potential roles. 
Dispensing separation was heavily discussed among all 
participants. The participants strongly insisted that 
currently without dispensing rights for pharmacists, it 
would be difficult to develop new pharmacist roles within 
the private GP clinics. The participants perceived that the 
GPs may also feel the redundancy of pharmacists’ roles in 
the clinic as GPs can treat common illnesses without the 
presence of pharmacists. Though majority of the 
participants were unable to envision the potential roles for 
pharmacists in private GP clinics, one-third of the 
participants saw the opportunity for pharmacists to be 
integrated into general practice as a way to help improve 
awareness and societal value of pharmacists within the 
Malaysian community.  
(ii) Perceived roles similar to pharmacists in public 
hospitals/clinics 
Upon prompting, participants envisaged the pharmacist’s 
role in private GP clinics to be similar to the current roles of 
pharmacists in public hospitals or public clinics (known 
locally as the ‘klinik kesihatan’). The medication therapy 
adherence clinic (MTAC) led by pharmacists in the public 
sector, was mentioned as an example among the 
participants. In these pharmacist-led clinic sessions, the 
pharmacist reviews the patient’s medications and discuss 
of any medication-related problems before referring them 
to see the GP. 
Theme 3: Lack of support and recognition by consumers 
and private GPs 
(i) Poor working relationship with private GPs 
All participants revealed that GPs and pharmacists do not 
work collaboratively. One participant termed the current 
relationship between pharmacists and GPs as “like 
enemies”. According to the participants, the poor working 
relationship between private GPs and pharmacists stem 
from the lack of dispensing separation and poor 
communication between the two professions. All 
participants also agreed that GPs’ acceptance and their 
willingness to work with the pharmacist in private GP clinics 
pose as a challenge to integration. Some participants 
indicated that private GPs were mostly concerned about 
pharmacists to taking over their roles and 
revenue/business. Overall, the participants felt that the 
working relationship between GPs and pharmacists needs 
to be improved before pharmacist integration into private 
GP clinic can take place. 
(ii) Lack of recognition from consumers 
A number of participants felt that the public often regarded 
doctors as a superior figure compared with pharmacists. 
The participants felt such public perception hinders the 
potential role for pharmacists.  
Theme 4: Cost implications from integrating pharmacists 
into private GP clinics 
The majority of participants agreed on a funding model 
where the consumers will pay for a pharmacist service in 
private GP clinics. Other potential funding options include 
joint venture between pharmacists and private GPs, and for 
pharmacists’ fee to be incorporated into dispensed 
medications. On whether the integrated pharmacists 
Table 1. Demographic characteristics of participants. (n=19) 
Characteristics Participants  
Interview method  
Focus Group 1 7 
Focus Group 2 8 
Semi-structured interviews 4 
Years of practice  
Less than 5 years 12 
5 to 10 years 4 
10 to 15 years 2 
More than 15 years 1 
Area of practice  
Community pharmacy 17 
Private hospital 2 
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should be paid by private GPs in the form of salary, most 
participants doubted if private GPs would pay a monthly 
salary of MYR 6,000 (approximately USD 1,700) for 
pharmacists to supply medications in the clinic. 
Even though most participants suggested a consumer 
funded model, they had concerns about consumers bearing 
the extra costs for the pharmacists’ service. The 
participants had mixed responses as to whether the 
consumers would be willing to pay for the pharmacist 
services. Some participants were confident that consumers 
would be willing to pay while some others felt that it 
depended on the type of service provided. However, the 
majority felt that consumers would not be willing to pay 
extra to pharmacists since dispensing and counselling 
services are currently provided free of charge. They cited 
incidences where consumers were already haggling for 
cheaper medications, thus making them question as to 
whether consumers would actually be willing to pay extra 
for pharmacists’ consultation if the new model were to 
Table 2. Themes and illustrative quotations 
Themes Illustrative quotations 
Pharmacists envisioning their main role as 
dispensing medications 
P3: So again it's quite dangerous in the sense that you tend to question or query about 
the safety of the medication because these technicians, they are basically not trained. So 
they will just follow whatever the doctor has written or ask them to do.  
P6: We, pharmacist (will) give out the medication instead of the nurses. 
P11: The pharmacist will be assigned to dispense medication and at the same time 
provide some advice or information to doctors. 
P2: I think that will a good thing because if there is any mistake or anything that the 
doctors do, pharmacists will be able to pick up so they sort of counter check on each 
other. 
Difficulty envisioning roles beyond medication 
supply  
(i) Limited roles for pharmacist in private GP 
clinics 
 
 
 
 
 
 
 
 
(ii) Perceived roles similar to pharmacists in 
public hospitals or clinics 
 
P11: So pharmacist will be assigned to be the person in charge for dispensing medication. 
And the same time can provide some advice or some information to doctors. 
P2: I’m not too sure what other services they (pharmacists) do (in a private clinic). Or 
perhaps I have not given much thought to it. 
P11: Maybe you can have some pilot study… see how is the outcome (about integrating 
pharmacist into clinic). 
P10: First thing is dispensing separation has to be done first la. Without this, we cannot 
do any further la. Like change dose, prescribe medication, all of this is beyond our scope. 
Now the limiting factor is the dispensing separation. 
P1: By seeing the common illnesses, I (as the GPs) can earn money also so why do I need 
to put a pharmacist in my store (clinic) just too maybe see what I’m doing. 
P1: People (will) know what pharmacists do instead of just dispensing (medication)… A 
lot of people don’t understand actually the role of pharmacist. So this will bring up the 
value of the pharmacist in Malaysia. 
P9: Like (in) klinik kesihatan, pharmacist actually do more than the dispensing role… the 
pharmacist makes an appointment with the patient, have a small group discussion or 
finding out the (medication-related) problem with the patient before referring to the GP. 
Lack of support and recognition by consumers 
and private GPs 
(i) Poor working relationship with private GPs 
 
 
 
 
 
 
(ii) Lack of recognition from consumers 
 
P4: Doctors are protecting their prescribing rights, pharmacist want their dispensing 
rights. Both are fighting for their own rights so it’s difficult to work closely for the time 
being because of the dispensing issue.  
P12: These days, pharmacist and GP are like enemies. We don’t communicate. 
P2: (The challenge would be) getting the doctors to work with pharmacist. 
P18: The major problem is the doctors view it as pharmacists trying to share a piece of 
their cake.  
P5: In order for this (pharmacist integration) to work, they (GPs and pharmacists) need to 
be able to work together. 
P14: For some people they don’t believe in pharmacist because they think that doctor is 
more superior, more competent. So we have to change the perception of the public. 
P9: Traditionally, Malaysian patients look up to doctors like God. So whatever the 
doctors say they will listen. So maybe we (pharmacists) are quite difficult to come in. 
Cost implications from integrating pharmacists 
into private GP clinics 
 
P18: I think from the doctor point of view is the cost. Because you may not want to hire 
someone, another 6 to 7k just to dispense medication. 
P10: The objective is good but it’s not practical… Even the doctors are cutting budget for 
their locums. 
P9: It’s something to think about because at the end of the day, the cost will be passed 
on to the consumers. So if you are going to adopt this idea, it's (medical bills) going to 
escalate even more. 
P10: The service charge, consultation also will be increased. They have to pay the 
consultation fees to doctor as well as the consultation fees for pharmacist. 
P13: I think if you (pharmacists) play your role well, I think yes (for consumers to pay). 
Why not? 
P9; Depends on what service (provided by pharmacist). 
P5: No, because in the first place they are already asking for cheaper prices for 
medications, what makes you think they will actually pay extra 5 ringgit for consultation. 
P2: If it’s out of their own pocket, no. I don’t think there’s such thing as pharmacist 
consultation fee or anything like that. 
P5: I suppose private clinics could actually get some sort subsidy from the government.  
(Note: ‘la’ is a suffix of no standard meaning used in the Malaysian colloquial)  
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come into practice. This opposes to the doctor’s 
consultation fees which are currently included in the 
treatment fee (including procedures and medications) as a 
lump sum, which consumers do not regard as an additional 
payment. A number of participants suggested for the 
government to provide financial support in the form of a 
subsidy to facilitate pharmacists’ integration into private 
GP clinic. 
 
DISCUSSION 
This study found that pharmacist participants felt that their 
main role in private GP clinics would be medication supply 
and had difficulty envisioning roles beyond that. The strong 
adherence to the traditional role of dispensing resonates 
with the article by Rosenthal et al. where the authors 
suggested that pharmacists have personality traits of 
paralysis in the face of ambiguity.22 The authors 
hypothesised that the biggest barrier to practice change is 
an existing underlying pharmacy culture that is resistant to 
change.22 This is in contrast to early career participants in 
this study, who were hungry for change and keenly 
interested in acting on that desire to expand their roles in 
the primary care. In literature, “early adopters” of practice 
innovations were typically described as being younger, 
more often seen as opinion leaders and more educated 
than their peers.38 Future implementation research should 
be directed in engaging these early adopters and their 
needs studied more closely, to facilitate successful 
pharmacy practice change. 
The opportunities and challenges discussed in the study 
reflected the needs for pharmacy training and education to 
keep pace with the expanding roles of pharmacists. 
Pharmacy students in Malaysia are trained in providing 
pharmaceutical care, but most of the time, pharmacy 
practice is concentrated on technical and retailing activities 
which may not allow the full use of their knowledge and 
skills.39 A Malaysian study on pharmacy student activities 
during clinical placements found that the common activities 
were related to supply of medications and packing of 
drugs.40 The mismatch between their training and current 
practice may not give them the opportunity to assume 
professional responsibility in patient care roles. The 
difficulty in envisioning roles beyond medication supply 
may also be due to the lack of exposure to be flexible in 
evolving models of practice and the fear of new 
responsibility.22 The schools of pharmacy therefore hold 
the responsibilities to equip the profession with the 
competency in terms of knowledge and skills to practice. 
Unless pharmacy graduates have been inculcated with this 
mind-set during their education, they may be reluctant to 
perform tasks beyond supply of medications. 
Lack of public’s trust towards pharmacists and absence of 
dispensing separation were expressed by participants as 
barriers to extend their roles into private GP clinics. 
Similarly, reports of lack of understanding in pharmacists’ 
roles by the community have also been shared in the 
international literature.41-43 In Taiwan, nearly 80% of 
consumers agreed that the only responsibility of a 
pharmacist was to accurately dispense medications as 
prescribed.33 The reason could be due to traditional belief 
that healthcare is solely the GPs’ responsibility as private 
GPs prescribe and supply medications at their clinics.  
Additionally most participants envisage pharmacists’ roles 
in private GP clinics would resemble those of which are 
observed in the public healthcare setting. Value-added 
services such as Medication Therapy Adherence Clinic 
(MTAC) involving medication management and disease 
monitoring are pharmacist-led activities provided in the 
public hospitals and clinics. These pharmacists work in close 
collaboration with their physicians to provide the best 
pharmaceutical care for the patients. Therefore, 
participants deemed activities similar to MTAC were 
suitable to be provided by an integrated pharmacist who 
would closely work in collaboration with the private GP in 
the clinic instead of independent pharmacy consultations 
by a community pharmacist. This was because Malaysian 
community pharmacists often reported lack of time, large 
workload and inadequate drug information sources as 
limitations in the provision of these services.45,46  
On separate studies, the Malaysian private GPs and 
consumers perceived integrated pharmacists to be helpful 
in roles beyond dispensing medication, including 
prescribing audits, medication review, drug information, 
education on therapeutic management of disease, patient 
advocacy and medication stock management.25,26 While 
integration provides greater opportunity for 
communication between pharmacist and GP, there 
remained concerns that pharmacists may remove parts of 
the GPs’ function and jeopardise the clinic’s business.25 In 
this study, working relationship between private GPs and 
pharmacists were found to be both a key barrier and 
facilitator to integrating a pharmacist into private GP 
clinics. This finding was similar to studies conducted by 
Freeman et al. and Tan et al.27,29 Antagonism between both 
professions is best explained by the long standing conflict 
between dispensing doctors and pharmacists, who are 
potentially in competition for business.47 The struggle over 
‘turf wars’ between doctors and pharmacists is nothing 
new in the implementation of clinical services in primary 
care.48-50 What often gets lost in these ‘turf wars’ is the 
consumers. Thus, healthcare consumers have highlighted 
the need of greater collaboration between GPs and 
pharmacists, and if barriers exist, these must be overcome 
before comprehensive inter-professional relationship can 
be realised.26 For pharmacist collaboration with GPs to be 
successful, there must also be a willingness from both 
parties to work together. The placement of highly trained 
pharmacists within GP clinics or ‘co-location’ can be 
considered for this purpose. Co-location of pharmacists and 
private GPs could increase rapport, professional trust and 
communication between the two professions.51 
Additionally, early working relationship may also be 
nurtured during their undergraduate years through inter-
professional education.52 By creating opportunities for 
early exposure and interaction, GPs and pharmacists can 
recognise and appreciate each other’s roles, thus building 
confidence and encouraging teamwork.  
Cost was also discussed heavily in this study. Most 
participants immediately identified pharmacist integration 
to an increased cost to private GPs which will consequently 
burden consumers. However, some participants saw this 
Saw PS, Nissen L, Freeman C, Wong PS, Mak V. A qualitative study on pharmacists’ perception on integrating pharmacists into 
private general practitioner’s clinics in Malaysia. Pharmacy Practice 2017 Jul-Sep;15(3):971.  
https://doi.org/10.18549/PharmPract.2017.03.971 
 
www.pharmacypractice.org (eISSN: 1886-3655 ISSN: 1885-642X) 7 
novel model as a means to reduce hospitalisations and cost 
through better quality use of medication. This finding was 
similar to that by Ramalho et al. and Isetts et al. which 
reported cost savings attributable to the integration of a 
pharmacist to a primary healthcare practice.31,53 In this 
study, although most participants felt that consumers 
would not be willing to pay extra for pharmacy services, a 
separate study on consumers’ willingness to pay for a 
pharmacy-based bone mineral density (BMD) testing in 
Malaysia showed otherwise. Eleven out of 17 participants 
would go to a pharmacy for BMD testing and be willing to 
pay the pharmacist between MYR 0 to MYR 50 
(approximately USD 12).54 It is also important to 
understand that for-profit, private sector providers will 
usually supply services for which individuals are willing to 
pay. They will tend not to provide services for which little 
demand exists. Decision-makers who wish to increase the 
coverage of effective public health interventions where 
members of the community do not see them as necessary 
or even desirable, face a particular challenge. Therefore, 
they need to stimulate demand. Where there is demand, 
and therefore willingness to pay, private sector healthcare 
providers will be more inclined to provide these services; 
although government supports and subsidies may still be 
necessary to raise coverage to the desired level.55 
When considering the study as a whole, the interpretation 
of the results may be limited by two main factors. Firstly, 
the project recruited participants who were mainly within 
the Klang Valley and highly urbanised areas. Although 
qualitative research, by its nature, served to provide insight 
into issues and experiences of participants, the number of 
participants recruited is often small. Also, the participants 
were not recruited using a random selection procedure. For 
these reasons, the results obtained may not be regarded as 
being representative of the Malaysian population as a 
whole. Nevertheless, findings from this study provided a 
better understanding to help ascertain the readiness and 
acceptance of pharmacists in a potential new model of 
practice. These results can be triangulated with local 
published data on perspectives from other stakeholders, 
giving a broader idea to the practice model. Future 
research should focus on achieving generalisation through 
a large-scale questionnaire and a retrospective review of 
pre- and post-integration study while providing guiding 
principles on successful integration. Outcomes describing 
characteristics of the pharmacist and primary healthcare 
setting, and how the pharmacist interacts within this 
setting could be investigated. 
 
CONCLUSIONS 
This study highlighted the perceived roles of pharmacists, 
barriers and facilitators of integrating pharmacists into 
private GP clinics. These findings have high strategic 
relevance to current directions of the pharmacy profession. 
Given the growing demand for healthcare services in our 
ageing population, this study has the potential to guide the 
pharmacy profession and pharmacists, towards accepting 
their responsibility within the healthcare system in the area 
of patient care. 
 
ACKNOWLEDGEMENT 
The authors would like to thank all participants for their 
contribution to this study. 
 
CONFLICT OF INTEREST 
No conflicts of interest have been declared. 
 
FUNDING 
This work was supported by the Exploratory Research 
Grant Scheme (ERGS) from the Ministry of Education (MOE) 
Malaysia [grant number ERGS/1/2013/SKK02/ IMU/03/2]. 
 
References 
 
1.  Jaafar S, Mohd Noh K, Abdul Muttalib K, Othman N, Healy J. Malaysia Health System Review. Health Systems in 
Transition 2013;3(1):1-103. 
2 Ramli A, Taher S. Managing chronic diseases in the Malaysian primary health care – a need for change. Malays Fam 
Physician. 2008;3(1):7-13 
3 Wong SS. Pharmacy practice in Malaysia. Malaysian Journal of Pharmacy 2001;1(1):2-8. 
4 Chua SS, Lim KP, Lee HG. Utilisation of community pharmacists by the general public in Malaysia. Int J Pharm Pract. 
2013;21(1):66-69. doi: 10.1111/j.2042-7174.2012.00219.x 
5 Chee HL. Ownership, control, and contention: challenges for the future of healthcare in Malaysia. Soc Sci Med. 
2008;66(10):2145-2156. doi: 10.1016/j.socscimed.2008.01.036 
6 Aljunid S. The role of private medical practitioners and their interactions with public health services in Asian countries. 
Health Policy Plan. 1995;10(4):333-349. 
7 Ministry of Health Malaysia. Country Health Plan: 10th Malaysia Plan 2011-2015. Available at: 
http://www.moh.gov.my/images/gallery/Report/Country_ health.pdf (accesed 29 December 2014). 
8 Fialová D, Onder G. Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol. 
2009;67(6):641-645. doi: 10.1111/j.1365-2125.2009.03419.x 
9 Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care 
patients in Germany. Fam Pract. 2007;24(1):14-19. doi: 10.1093/fampra/cml067 
10 Freeman CR, Cottrell WN, Kyle G, Williams ID, Nissen L. An evaluation of medication review reports across different 
settings. Int J Clin Pharm. 2013;35(1):5-13. doi: 10.1007/s11096-012-9701-8 
11 Chua SS, Kok LC, Md Yusof FA, Tang GH, Lee SWH, Efendie B, Paraidathathu T. Pharmaceutical care issues identified 
by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings. BMC Health Serv Res. 
2012;12:388. doi: 10.1186/1472-6963-12-388 
Saw PS, Nissen L, Freeman C, Wong PS, Mak V. A qualitative study on pharmacists’ perception on integrating pharmacists into 
private general practitioner’s clinics in Malaysia. Pharmacy Practice 2017 Jul-Sep;15(3):971.  
https://doi.org/10.18549/PharmPract.2017.03.971 
 
www.pharmacypractice.org (eISSN: 1886-3655 ISSN: 1885-642X) 8 
12 Dolovich L, Pottie K, Kaczorowski J, Farrell B, Austin Z, Rodriguez C, Gaebel K, Sellors C. Integrating family medicine 
and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther. 2008;83(6):913-917. doi: 10.1038/clpt.2008.29 
13 Fish A, Watson MC, Bond CM. Practice-based pharmaceutical services: a systematic review. Int J Pharm Pract. 
2002;10(4):225–233. doi: 10.1211/096176702776868451 
14 Ables AZ, Baughman OL 3rd. The clinical pharmacist as a preceptor in a family practice residency training program. Fam 
Med. 2002;34(9):658-662. 
15 Cone SM, Brown MC, Stambaugh RL. Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs 
medical centers: an update. Am J Health Syst Pharm. 2008;65(7):631-635. doi: 10.2146/ajhp070198 
16 Martin RM, Lunec SG, Rink E. UK postal survey of pharmacists working with general practices on prescribing issues: 
characteristics, roles and working arrangements. Int J Pharm Pract. 1998;6(3):133-139. 
17 Carter BL, Malone DC, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, Ellis S, Covey D, Mason B, Jue S, Carmichael J, 
Guthrie K, Dombrowski R, Geraets DR, Amato M; Impact of Managed Pharmaceutical care on resource utilization and 
Outcomes in Veterans affairs medical centers. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm. 
2001;58(14):1330-1337. 
18 Lowe CJ, Raynor DK, Purvis J, Farrin A, Hudson J. Effects of a medicine review and education programme for older 
people in general practice. Br J Clin Pharmacol. 2000;50(2):172-175. 
19 Farrell B, Ward N, Dore N, Russell G, Geneau R, Evans S. Working in interprofessional primary health care teams: What 
do pharmacists do? Res Social Adm Pharm. 2013;9(3):288-301. doi: 10.1016/j.sapharm.2012.05.005 
20 Low WH, Seet W, Ramli AS, Ng KK, Jamaiyah H, Dan SP, Teng CL, Lee VK, Chua SS, Md Yusof FA, Karupaiah T, Chee 
WS, Goh PP, Zaki M, Lim TO. Community-based cardiovascular Risk Factors Intervention Strategies (CORFIS) in 
managing hypertension: A pragmatic non-randomised controlled trial. Med J Malaysia. 2013;68(2):129-135. 
21 Frankel GE, Austin Z. Responsibility and conﬁdence: identifying barriers to advanced pharmacy practice. Can Pharm J 
(Ott). 2013;146(3):155-161. doi: 10.1177/1715163513487309 
22 Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J (Ott) 
2010;143:37-42. 
23 Hassali M, Awaisu A, Shafie A. Professional Training and Roles of Community Pharmacists in Malaysia: Views from 
General Medical Practitioners. Malays Fam Physician. 2009;4(2-3):71-76 
24 Sarriff A, Nordin N, Hassali MA. Extending the Roles of Community Pharmacists: Views from General Medical 
Practitioners. Med J Malaysia. 2012;67(6):577-581. 
25 Saw PS, Nissen L, Freeman C, Wong PS, Mak V. A new role of pharmacists in private primary healthcare clinics in 
Malaysia: the views of general practitioners. J Pharm Pract Res 2017;47(1):27-33. 
26 Saw PS, Nissen LM, Freeman C, Wong PS, Mak V. Health care consumers' perspectives on pharmacist integration into 
private general practitioner clinics in Malaysia: a qualitative study. Patient Prefer Adherence. 2015;9:467-477. doi: 
10.2147/PPA.S73953 
27 Freeman C, Cottrell WN, Kyle G, Williams I, Nissen L. Integrating a pharmacist into the general practice environment: 
opinions of pharmacist's, general practitioner's, health care consumer's, and practice manager's. BMC Health Serv Res. 
2012;12:229. doi: 10.1186/1472-6963-12-229 
28 Jorgenson D, Laubscher T, Lyons B, Palmer R. Integrating pharmacists into primary care teams: barriers and facilitators. 
Int J Pharm Pract. 2014;22(4):292-299. doi: 10.1111/ijpp.12080 
29 Tan EC, Stewart K, Elliott RA, George J. Integration of pharmacists into general practice clinics in Australia: the views of 
general practitioners and pharmacists. Int J Pharm Pract. 2014;22(1):28-37. doi: 10.1111/ijpp.12047 
30 Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: A systematic review of 
remunerated pharmacy clinical care services. Can Pharm J (Ott). 2014;147(4):209-232. doi: 10.1177/1715163514536678 
31 Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, Brown LM, Cipolle RJ. Clinical and economic 
outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc (2003). 2008 Mar-
Apr;48(2):203-211. doi: 10.1331/JAPhA.2008.07108 
32 Thompson CA. State-paid medication therapy management services succeed. Am J Health Syst Pharm. 2008;65(6):490- 
498. doi: 10.2146/news080022 
33 Lee E, Braund R, Tordoff J. Examining the first year of Medicines Use Review services provided by pharmacists in New 
Zealand: 2008. N Z Med J. 2009;122(1293):3566. 
34 Jackson M, Gaspic-Piskovic M, Cimino S. Description of a Canadian employer-sponsored smoking cessation program 
utilizing community pharmacy-based cognitive services. Can Pharm J (Ott) 2008;141(4):234-240.  
35 Look KA, Mott DA, Leedham RK, Kreling DH, Hermansen-Kobulnicky CJ. Pharmacy participation and claim 
characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007. J Manag Care Pharm. 2012 
Mar;18(2):116-128. doi: 10.18553/jmcp.2012.18.2.116 
36 Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and 
health services research. BMJ. 1995;311(6996):42-45. 
37 Thomas D. A General Inductive Approach for Analyzing Qualitative Evaluation Data. Am J Eval 2006;27(2):237-246.  
38 Jorgenson D, Gubbels-Smith A, Farrell B, Ward N, Dolovich L, Jennings B. Characteristics of pharmacists who enrolled in 
the pilot ADAPT Education Program: Implications for practice change. Can Pharm J (Ott). 2012;145(6):260-263. doi: 
10.3821/145.6.cpj260 
39 Hassali MA, Shafie AA, Awaisu A, Mohamed Ibrahim MI, Ahmed SI. A public health pharmacy course at a Malaysian 
pharmacy school. Am J Pharm Educ. 2009;73(7):136. 
40 Ting KN, Wong KT, Thang SM. Contributions of Early Work-Based Learning: A Case Study of First Year Pharmacy 
Students. International Journal of Teaching and Learning in Higher Education 2009;22(3):326-335.  
Saw PS, Nissen L, Freeman C, Wong PS, Mak V. A qualitative study on pharmacists’ perception on integrating pharmacists into 
private general practitioner’s clinics in Malaysia. Pharmacy Practice 2017 Jul-Sep;15(3):971.  
https://doi.org/10.18549/PharmPract.2017.03.971 
 
www.pharmacypractice.org (eISSN: 1886-3655 ISSN: 1885-642X) 9 
41 Olsson E, Tuyet LT, Nguyen HA, Stalsby Lundborg C. Health professionals' and consumers' views on the role of the 
pharmacy personnel and the pharmacy service in Hanoi, Vietnam: a qualitative study. J Clin Pharm Ther. 2002;27(4):273-
280. 
42 Kamei M, Teshima K, Fukushima N, Nakamura T. Investigation of patients' demand for community pharmacies: 
relationship between pharmacy services and patient satisfaction. Yakugaku Zasshi. 2001;121(3):215-220. 
43 Kamat VR, Nichter M. Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Soc Sci Med. 
1998;47(6):779-794. 
44 Wen MF, Lin SJ, Yang YH, Huang YM, Wang HP, Chen CS, Wu FL. Effects of a national medication education program in 
Taiwan to change the public's perceptions of the roles and functions of pharmacists. Patient Educ Couns. 2007;65(3):303-
310. doi: 10.1016/j.pec.2006.08.011 
45 Sarriff A. A survey of patient-oriented services in community pharmacy practice in Malaysia. J Clin Pharm Ther. 
1994;19(1):57-60. 
46 Hassali MA, Subish P, Shafie AA, Ibrahim MIM. Perceptions and Barriers towards Provision of Health Promotion Activities 
among Community Pharmacists in the State of Penang, Malaysia. J Clin Diagn Res 2009;3(3):1562-1568.  
47 Amzan K. Pharmacists vs doctors: The ongoing 'debate'. The Malay Mail Online 2015. Available at: 
http://www.themalaymailonline.com/opinion/kamal-amzan/article/pharmacists-vs-doctors-the-ongoing-debate (accessed 
17 June 2015). 
48 McDonough RP, Rovers JP, Currie JD, Hagel H, Vallandinghanl J, Sobotka J. Obstacles to the implementation of 
pharmaceutical care in the community setting. J Am Pharm Assoc 1998;38(1):87-95. doi: 10.1016/S1086-5802(16)30296-
0 
49 Kucukarslan S, Lai S, Dong Y, Al-Bassam N, Kim K. Physician beliefs and attitudes toward collaboration with community 
pharmacists.  Res Social Adm Pharm. 2011;7(3):224-232. doi: 10.1016/j.sapharm.2010.07.003 
50 Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a 
qualitative assessment. Br J Gen Pract. 2003;53(493):600-606. 
51 Bradley F, Elvey R, Ashcroft DM, Hassell K, Kendall J, Sibbald B, Noyce P. The challenge of integrating community 
pharmacists into the primary health care team: a case study of local pharmaceutical services (LPS) pilots and 
interprofessional collaboration. J Interprof Care. 2008;22(4):387-98. doi: 10.1080/13561820802137005 
52 Van C, Costa D, Abbott P, Mitchell B, Krass I. Community pharmacist attitudes towards collaboration with general 
practitioners: development and validation of a measure and a model. BMC Health Serv Res. 2012;12:320. doi: 
10.1186/1472-6963-12-320 
53 Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large 
integrated health care system. J Manag Care Pharm. 2010;16(3):185-195. doi: 10.18553/jmcp.2010.16.3.185 
54 Jacob S, Sarriff A. An explorative study of pharmacy-based bone mineral density testing. Malaysian J Pharm Sci. 
2006;4(2):1-14.  
55 Swan M, Zwi A. Private practitioners and public health: close the gap or increase the distance. Department of Public 
Health and Policy, London School of Hygiene and Tropical Medicine;1997. 
